
|Articles|June 1, 2017
- Pharmaceutical Executive-06-01-2017
- Volume 37
- Issue 6
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Pharm Exec's Top 50 Companies 2017about 9 years ago
Navigating Through Disruption: A Pharma 50 Viewabout 9 years ago
Tips for Success from a Big Pharma Leaderabout 9 years ago
The Quest for Meaningful Pharma-Patient Dialogueabout 9 years ago
Executive Roundtable: Where is Your Physician?about 9 years ago
Talent That Takes You into the Futureabout 9 years ago
Europe: A Long Summer of Drug Pricing Tensionabout 9 years ago
Gottlieb Takes Reins at FDA, Big Issues Loomabout 9 years ago
Country Report: TaiwanAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
4
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
5




